Find policies, billing codes, payers, states, and providers

CPT 87255: Viral Identification by Cell Impact Analysis

CPT code 87255 represents a laboratory virology procedure used to identify a virus by observing how it affects and damages cells, using methods other than immunologic assays or evaluation of cytopathic effect. This code captures specialized virology testing performed in clinical or hospital laboratory settings and is relevant for laboratories, hospital billing teams, and payers that cover advanced diagnostic virology.

Key payers in national coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for the test, typical sites of service, and the role of this code in laboratory billing. The summary highlights common modifiers associated with the service and notes when input data is not provided.

This publication also outlines what readers can expect regarding benchmarks and policy context: an overview of reimbursement considerations, common billing practices for specialized virology testing, and where to find related procedural and coding guidance. Data not available in the input is clearly indicated where applicable. The content is intended for a national audience of laboratory administrators, billing professionals, and policy analysts seeking a practical briefing on CPT code 87255 and its clinical and billing implications.

Customize your policy alerts

Sign up for cpt 87255 policy alerts

Get alerted when payer policies referencing 87255 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

CPT code 87255 describes a laboratory test in which a lab analyst identifies a virus using methods other than immunologic assays or evaluation of cytopathic effect, focusing on how the virus impacts and damages cells. This procedure involves direct observation and analysis of viral effects on cultured cells or similar preparations.

Service type: Viral identification by cell impact/damage observation (non-immunologic, non-cytopathic-effect evaluation)
Typical site of service: Clinical laboratory or hospital laboratory setting where virology culture and microscopy are performed

Find policies, billing codes, payers, states, and providers

CPT 87255: Viral Identification by Cell Impact Analysis

Customize your policy alerts

Sign up for cpt 87255 policy alerts

Get alerted when payer policies referencing 87255 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service type: Viral identification by cell impact/damage observation (non-immunologic, non-cytopathic-effect evaluation)
Typical site of service: Clinical laboratory or hospital laboratory setting where virology culture and microscopy are performed

Clinical & Coding Specifications

Clinical Context

A middle-aged adult presents to an outpatient infectious disease laboratory with symptoms of an acute viral illness such as fever, malaise, and respiratory or enteric symptoms. A clinical specimen (e.g., nasopharyngeal swab, stool, or tissue culture) is sent to the virology lab for identification of an etiologic virus using non-immunologic methods that evaluate viral effects on cultured cells (cytopathic effect) and/or alternative molecular/virus identification techniques described by the test method. The lab analyst receives the specimen, documents specimen integrity and labeling, inoculates appropriate cell cultures or performs other specified non-immunologic viral identification methods, incubates and monitors cultures for cytopathic changes, and performs confirmatory testing (e.g., molecular sequencing or PCR-based assays if part of the technique) to identify the viral species or strain. Results are reported to the ordering clinician, such as an infectious disease specialist, pediatrician, hospitalist, or primary care provider, for clinical correlation and management.

Typical site of service: Hospital clinical virology laboratory, reference laboratory, or academic medical center virology lab.

Typical patient scenario: An adult with worsening cough and hypoxia after outpatient treatment; a nasopharyngeal swab is submitted for viral identification to guide antiviral therapy and infection control. The lab performs culture-based observation of cytopathic effect and molecular confirmation consistent with the described methodology.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting the professional interpretation component separate from technical services if applicable and payer allows split billing.
`59`	Distinct procedural service	Use when this viral identification test is a distinct service separate from other laboratory procedures on the same day.
`62`	Two surgeons	Rare for lab code; use only if two qualified laboratory directors are necessary for complex specialized testing as allowed by payer.
`90`	Reference (outside) laboratory	Use when the service is performed by an outside/reference laboratory.
`91`	Repeat clinical diagnostic laboratory test	Use when the same viral identification test is repeated on the same day for a given patient.
`52`	Reduced services	Use when the full service described by the code was partially reduced or not completed.
`53`	Discontinued procedure	Use when testing was started but discontinued due to specimen issues or early termination.
`90`	Reference (outside) laboratory	Use when testing is performed by an external reference laboratory (duplicate entry avoided by payer rules).
`TC`	Technical component	Use when billing only the technical component (laboratory processing, culture maintenance) separate from interpretation.
`QW`	CLIA waived test	Do not use generally for complex virology culture tests; include only if a specific component is CLIA-waived per manufacturer instructions.

Taxonomy Code	Specialty	Notes
207Q00000X	Pathology	Clinical microbiology/virology laboratory directors and pathologists who oversee viral testing.
208000000X	Infectious Disease	Infectious disease physicians ordering and interpreting specialized viral identification.
174400000X	Laboratory Medicine	Clinical laboratory specialists and medical technologists performing virology testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J10.1`	Influenza due to other identified influenza virus with other respiratory manifestations	Viral identification by culture or non-immunologic methods can confirm influenza strain for treatment and surveillance.
`J12.9`	Viral pneumonia, unspecified	Identification of the causative virus informs antiviral therapy and infection control measures.
`B34.9`	Viral infection, unspecified	Used when a viral etiology is suspected but specific agent not yet identified; culture-based identification clarifies diagnosis.
`A08.4`	Viral enteritis	Enteric viruses may be identified by culture or specialized non-immunologic methods for outbreak investigation.
`B20`	Human immunodeficiency virus [HIV] disease	Specialized virology methods may be used to identify or characterize opportunistic viral infections in immunocompromised patients.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87255`	Identification of virus by methods other than immunologic assays or evaluation of cytopathic effect that involves observing how a virus impacts and damages cells	Primary code describing laboratory identification of virus using non-immunologic, culture-based or equivalent methods.
`87631`	Infectious agent detection by nucleic acid (DNA or RNA); SARS-CoV-2, amplified probe technique	Common molecular test performed before, alongside, or after culture-based methods for faster detection and confirmation.
`87661`	Infectious agent detection by nucleic acid (DNA or RNA); influenza A and B, includes multiplex panels	Frequently ordered in respiratory illness workups; may be used in parallel to or prior to culture-based identification.
`87471`	Infectious agent antigen detection by immunoassay; influenza A	Rapid antigen or immunologic assays are often performed as initial testing; culture-based identification is used for confirmation or strain typing.
`87507`	Infectious agent antibody; viral serology (e.g., enteric viruses)	Serologic testing can complement culture results for diagnosis of acute or recent infection.

CPT 87250: Viral Isolation in Embryonated Egg or Small Animal

CPT-87252-VIRAL-CULTURE-IDENTIFICATION-TISSUE-CULTURE

CPT 87252: Viral Culture Identification by Tissue Culture

CPT-87253-VIRAL-IDENTIFICATION-AFTER-TISSUE-CULTURE

CPT 87253: Viral Identification After Tissue Culture

CPT-87254-SHELL-VIAL-VIRAL-CULTURE-IMMUNOFLUORESCENCE

CPT 87254: Shell Vial Viral Culture with Immunofluorescence

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical & Coding Specifications

Clinical Context

Typical site of service: Hospital clinical virology laboratory, reference laboratory, or academic medical center virology lab.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting the professional interpretation component separate from technical services if applicable and payer allows split billing.
`59`	Distinct procedural service	Use when this viral identification test is a distinct service separate from other laboratory procedures on the same day.
`62`	Two surgeons	Rare for lab code; use only if two qualified laboratory directors are necessary for complex specialized testing as allowed by payer.
`90`	Reference (outside) laboratory	Use when the service is performed by an outside/reference laboratory.
`91`	Repeat clinical diagnostic laboratory test	Use when the same viral identification test is repeated on the same day for a given patient.
`52`	Reduced services	Use when the full service described by the code was partially reduced or not completed.
`53`	Discontinued procedure	Use when testing was started but discontinued due to specimen issues or early termination.
`90`	Reference (outside) laboratory	Use when testing is performed by an external reference laboratory (duplicate entry avoided by payer rules).
`TC`	Technical component	Use when billing only the technical component (laboratory processing, culture maintenance) separate from interpretation.
`QW`	CLIA waived test	Do not use generally for complex virology culture tests; include only if a specific component is CLIA-waived per manufacturer instructions.

Taxonomy Code	Specialty	Notes
207Q00000X	Pathology	Clinical microbiology/virology laboratory directors and pathologists who oversee viral testing.
208000000X	Infectious Disease	Infectious disease physicians ordering and interpreting specialized viral identification.
174400000X	Laboratory Medicine	Clinical laboratory specialists and medical technologists performing virology testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J10.1`	Influenza due to other identified influenza virus with other respiratory manifestations	Viral identification by culture or non-immunologic methods can confirm influenza strain for treatment and surveillance.
`J12.9`	Viral pneumonia, unspecified	Identification of the causative virus informs antiviral therapy and infection control measures.
`B34.9`	Viral infection, unspecified	Used when a viral etiology is suspected but specific agent not yet identified; culture-based identification clarifies diagnosis.
`A08.4`	Viral enteritis	Enteric viruses may be identified by culture or specialized non-immunologic methods for outbreak investigation.
`B20`	Human immunodeficiency virus [HIV] disease	Specialized virology methods may be used to identify or characterize opportunistic viral infections in immunocompromised patients.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87255`	Identification of virus by methods other than immunologic assays or evaluation of cytopathic effect that involves observing how a virus impacts and damages cells	Primary code describing laboratory identification of virus using non-immunologic, culture-based or equivalent methods.
`87631`	Infectious agent detection by nucleic acid (DNA or RNA); SARS-CoV-2, amplified probe technique	Common molecular test performed before, alongside, or after culture-based methods for faster detection and confirmation.
`87661`	Infectious agent detection by nucleic acid (DNA or RNA); influenza A and B, includes multiplex panels	Frequently ordered in respiratory illness workups; may be used in parallel to or prior to culture-based identification.
`87471`	Infectious agent antigen detection by immunoassay; influenza A	Rapid antigen or immunologic assays are often performed as initial testing; culture-based identification is used for confirmation or strain typing.
`87507`	Infectious agent antibody; viral serology (e.g., enteric viruses)	Serologic testing can complement culture results for diagnosis of acute or recent infection.

CPT 87250: Viral Isolation in Embryonated Egg or Small Animal

CPT-87252-VIRAL-CULTURE-IDENTIFICATION-TISSUE-CULTURE

CPT 87252: Viral Culture Identification by Tissue Culture

CPT-87253-VIRAL-IDENTIFICATION-AFTER-TISSUE-CULTURE

CPT 87253: Viral Identification After Tissue Culture

CPT-87254-SHELL-VIAL-VIRAL-CULTURE-IMMUNOFLUORESCENCE

CPT 87254: Shell Vial Viral Culture with Immunofluorescence

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

CPT 87255: Viral Identification by Cell Impact Analysis

Sign up for cpt 87255 policy alerts

Billing Code Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

CPT 87255: Viral Identification by Cell Impact Analysis

Sign up for cpt 87255 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References